Medical Condition News

RSS

Boston Scientific launches Epic Vascular Self-Expanding Stent System

Boston Scientific Corporation announces U.S. Food and Drug Administration approval and market launch of the Epic Vascular Self-Expanding Stent System.

18 May 2012

Medgenics’ EPODURE receives FDA clearance to proceed into clinical trials

Medgenics, Inc., developer of the novel Biopump technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced receipt of clearance from the U.S. Food and Drug Administration to proceed with a Phase IIb clinical trial of EPODURE for the treatment of anemia in patients undergoing renal dialysis.

18 May 2012

Mylan receives final FDA approval for Clopidogrel Tablets ANDA

Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Clopidogrel Tablets USP, 75 mg and 300 mg.

18 May 2012

Spectrum initiates ZEVALIN and MGd Phase 2 combination study in NHL

Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced the initiation of a Phase 2 study evaluating ZEVALIN (ibritumomab tiuxetan) Injection for intravenous use + rituximab in combination with motexafin gadolinium (MGd) in patients with rituximab-refractory low-grade or follicular B-cell non-Hodgkin's lymphoma.

18 May 2012

Covidien launches new HALO ablation catheter to treat Barrett's esophagus

Covidien, a leading global provider of healthcare products, today announced the launch of the HALO90 ULTRA Ablation Catheter, the latest addition to the HALO family of catheters for the endoscopic treatment of Barrett's esophagus.

18 May 2012

Kudzu root components may treat alcoholism and curb binge drinking

An extract of the Chinese herb kudzu dramatically reduces drinking and may be useful in the treatment of alcoholism and curbing binge drinking, according to a new study by McLean Hospital and Harvard Medical School researchers.

18 May 2012

Multiple companies receive FDA approval to sell generic Plavix

The U.S. Food and Drug Administration today approved generic versions of the blood thinning drug Plavix (clopidogrel bisulfate), which helps reduce the risk of heart attack and stroke by making it less likely that platelets in the blood will clump and form clots in the arteries.

18 May 2012

Generic versions of Lipitor to hit pharmacy shelves

In just days, a number of generic versions of Lipitor will hit pharmacy shelves. Pfizer's 180-day generic exclusivity agreement for the medication expires at the end of the month. That will bring a host of new generic alternatives, and potential confusion, to more than 3 million Americans looking to control their cholesterol and reduce the cost of their drug therapies.

17 May 2012

Scientists investigate how ApoE4 gene contributes to Alzheimer's disease

A well-known genetic risk factor for Alzheimer's disease triggers a cascade of signaling that ultimately results in leaky blood vessels in the brain, allowing toxic substances to pour into brain tissue in large amounts, scientists report May 16 in the journal Nature.

17 May 2012

$Age alone is not a contraindication to surgical fixation of C2 fractures$

Age alone is not a contraindication to surgical fixation of C2 fractures

For older adults with "C2" fractures of the upper (cervical) spine, surgery and nonsurgical treatment provide similar short- and long-term outcomes, reports a study in the May issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.

17 May 2012

Insight into why diabetics suffer from increased pain and temperature sensitivity

Why diabetics suffer from increased pain and temperature sensitivity is a step closer to being understood and effectively treated.

17 May 2012

Lenalidomide following stem cell transplant can halt progression of blood cancer

Multiple myeloma patients are better equipped to halt progression of this blood cancer if treated with lenalidomide, or Revlimid-, following a stem cell transplant, according to a study co-authored by a physician with the Oregon Health & Science University Knight Cancer Institute.

17 May 2012

Cardiac ischemia plays an important role in adenovector gene transfection in mammalian hearts

Cardium Therapeutics today announced a late-breaking poster presentation at the American Society of Gene & Cell Therapy (ASGCT) 15th Annual Meeting being held May 16-19, 2012 at the Pennsylvania Convention Center in Philadelphia, PA.

17 May 2012

Sensory substitution device enables blind persons to actually 'read' an eye chart

A method developed at the Hebrew University of Jerusalem for training blind persons to "see" through the use of a sensory substitution device (SSD) has enabled those using the system to actually "read" an eye chart with letter sizes smaller than those used in determining the international standard for blindness.

17 May 2012

Damage to brain white matter connections may be the cause of Phineas Gage's behavioral changes

Poor Phineas Gage. In 1848, the supervisor for the Rutland and Burlington Railroad in Vermont was using a 13-pound, 3-foot-7-inch rod to pack blasting powder into a rock when he triggered an explosion that drove the rod through his left cheek and out of the top of his head. As reported at the time, the rod was later found, "smeared with blood and brains."

17 May 2012

Paper-based diabetes device can be adapted for other applications

With epidemics of Type 2 diabetes looming in rural India, China and other areas of the world where poverty limits the availability of health care, scientists are reporting development of an inexpensive and easy-to-use urine test ideally suited for such areas. The report describing the paper-based device, which also could be adapted for the diagnosis and monitoring of other conditions and the environment, appears in ACS' journal Analytical Chemistry.

17 May 2012

MedWorks and its partners to offer two days of free cancer screenings

On Saturday, June 2, and Sunday, June 3, 2012, MedWorks, its partners The Free Medical Clinic of Greater Cleveland, University Hospitals Seidman Cancer Center and the Cleveland Clinic-Taussig Cancer Center, and volunteers will provide two days of free cancer screenings at a MedWorks clinic held at The Free Medical Clinic of Greater Cleveland, 12201 Euclid Avenue, Cleveland, Ohio 44106.

17 May 2012